Literature DB >> 7510310

Modified CAMP test for biogrouping Vibrio cholerae O1 strains and distinguishing them from strains of V. cholerae non-O1.

M Lesmana1, D Subekti, P Tjaniadi, G Pazzaglia.   

Abstract

A modified CAMP test was used to identify 973 Vibrio cholerae isolates by phenotype. Eltor and non-O1 strains were CAMP positive; classical strains were CAMP negative. Sausage-shaped zones of hemolysis of eltor strains were easily distinguished from narrower bands of non-O1 isolates. For O1 isolates, there was 100% agreement between the CAMP test and inhibition by polymyxin B.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7510310      PMCID： PMC263006          DOI： 10.1128/jcm.32.1.235-237.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  An evaluation of the CAMP test for the identification of Streptococcus agalactiae in routine mastitis testing.

Authors:  J M MURPHY; O M STUART; F I REED
Journal:  Cornell Vet       Date:  1952-01

2.  Synergistic hemolysis phenomenon shown by an alpha-toxin-producing Clostridium perfingens and streptococcal CAMP factor in presumptive streptococcal grouping.

Authors:  S M Gubash
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

3.  Presumptive identification of group A, B, and D streptococci on agar plate media.

Authors:  R R Facklam; J F Padula; E C Wortham; R C Cooksey; H A Rountree
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

4.  CAMP-like phenomena of Vibrios.

Authors:  W Köhler
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1988-11

5.  Outbreak of Vibrio cholerae non-O1 in India and Bangladesh.

Authors:  M K Bhattacharya; S K Bhattacharya; S Garg; P K Saha; D Dutta; G B Nair; B C Deb; K P Das
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

6.  Differentiation of motile and mesophilic Aeromonas strains into species by testing for a CAMP-like factor.

Authors:  N Figura; P Guglielmetti
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

7.  A CAMP phenomenon between Vibrio cholerae biotype El Tor and staphylococcal B-hemolysin.

Authors:  M Lesmana; R C Rockhill
Journal:  Southeast Asian J Trop Med Public Health       Date:  1985-06       Impact factor: 0.267

8.  Separation of pathogenic from apathogenic Listeria monocytogenes by three in vitro reactions.

Authors:  R D Groves; H J Welshimer
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948
  8 in total
  6 in total

1.  Phenotypic and genotypic changes in Vibrio cholerae O139 Bengal.

Authors:  M J Albert; N A Bhuiyan; K A Talukder; A S Faruque; S Nahar; S M Faruque; M Ansaruzzaman; M Rahman
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  Simple differentiation of Vibrio cholerae O139 from V. cholerae O1 and non-O1, non-O139 by modified CAMP test.

Authors:  M Lesmana; M J Albert; D Subekti; E Richie; P Tjaniadi; S E Walz; C I Lebron
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

3.  Mechanisms of inflammasome activation by Vibrio cholerae secreted toxins vary with strain biotype.

Authors:  Jessica Queen; Shivani Agarwal; Jazel S Dolores; Christian Stehlik; Karla J F Satchell
Journal:  Infect Immun       Date:  2015-04-06       Impact factor: 3.441

Review 4.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

5.  El Tor Biotype Vibrio cholerae Activates the Caspase-11-Independent Canonical Nlrp3 and Pyrin Inflammasomes.

Authors:  Michail Mamantopoulos; Ulrika C Frising; Tomoko Asaoka; Geert van Loo; Mohamed Lamkanfi; Andy Wullaert
Journal:  Front Immunol       Date:  2019-10-29       Impact factor: 7.561

Review 6.  Molecular tools in understanding the evolution of Vibrio cholerae.

Authors:  Md Habibur Rahaman; Tarequl Islam; Rita R Colwell; Munirul Alam
Journal:  Front Microbiol       Date:  2015-10-06       Impact factor: 5.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.